NCT06036186 - Study for the Treatment of Heart Failure With Preserved Ejection Fraction Associated With High Blood Pressure Using Right Atrial Pacing Controlled by the PressurePaceTM System | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 26, 2023

Primary Completion Date

April 12, 2024

Study Completion Date

April 12, 2024

Conditions

Heart Failure With Preserved Ejection Fraction (HFpEF)Hypertension

Interventions

DEVICE

BaroPacing treatment

BaroPacing for the first 3 weeks (day 8 to day 28) and then crossover to standard treatment for another 3 weeks (day 29 to day 49).

DEVICE

Standard treatment

Individual Standard treatment as prescribed by the Physician to each subject for the first 3 weeks (day 8 to day 28) and then crossover to BaroPacing for another 3 weeks (day 29 to day 49).

Trial Locations (3)

208002

L.P.S. Institute of Cardiology, G.S.V.M Medical College, Kanpur

302039

Maharaja Agrasen Superspeciality Hospital, Clinical Research Department, Basement, Main Building, Room No-09, Sector-07, Agrasen Aspatal Marg, Central Spine, Vidyadhar Nagar,, Jaipur

303702

Dr. C. M. Chopra Hospital & Heart Care Centre, Jaipur